AstraZeneca Challenge To Medicare Drug Price Program Fails
A Delaware federal judge on Friday rejected AstraZeneca's challenge to the Medicare price negotiation program, upholding the Biden administration's argument that the talks are voluntary....To view the full article, register now.
Already a subscriber? Click here to view full article